ZOPPELLARO, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 4.624
AS - Asia 2.521
EU - Europa 1.085
SA - Sud America 415
AF - Africa 313
Continente sconosciuto - Info sul continente non disponibili 80
OC - Oceania 27
Totale 9.065
Nazione #
US - Stati Uniti d'America 4.414
SG - Singapore 735
VN - Vietnam 506
CN - Cina 437
BR - Brasile 245
HK - Hong Kong 223
IT - Italia 204
DE - Germania 111
BD - Bangladesh 95
GB - Regno Unito 80
FR - Francia 77
IN - India 77
FI - Finlandia 72
SE - Svezia 62
NL - Olanda 60
CA - Canada 50
PL - Polonia 49
TR - Turchia 42
RU - Federazione Russa 41
JP - Giappone 39
IQ - Iraq 38
IE - Irlanda 32
UA - Ucraina 30
AR - Argentina 29
EC - Ecuador 28
PH - Filippine 26
SA - Arabia Saudita 24
ZA - Sudafrica 23
BE - Belgio 22
CO - Colombia 22
ID - Indonesia 22
CI - Costa d'Avorio 20
VE - Venezuela 19
MX - Messico 18
PK - Pakistan 18
ES - Italia 17
BJ - Benin 16
JM - Giamaica 16
CZ - Repubblica Ceca 15
HN - Honduras 15
TH - Thailandia 15
AT - Austria 14
CL - Cile 14
PE - Perù 14
GR - Grecia 13
KG - Kirghizistan 13
LB - Libano 13
PY - Paraguay 13
TN - Tunisia 13
UZ - Uzbekistan 13
AM - Armenia 12
BA - Bosnia-Erzegovina 12
BY - Bielorussia 12
CH - Svizzera 12
IR - Iran 12
KZ - Kazakistan 12
MA - Marocco 12
RO - Romania 12
RS - Serbia 12
UY - Uruguay 12
BS - Bahamas 11
EG - Egitto 11
MY - Malesia 11
PT - Portogallo 11
SK - Slovacchia (Repubblica Slovacca) 11
AZ - Azerbaigian 10
BO - Bolivia 10
CR - Costa Rica 10
CY - Cipro 10
IS - Islanda 10
JO - Giordania 10
KH - Cambogia 10
MZ - Mozambico 10
NP - Nepal 10
SY - Repubblica araba siriana 10
TW - Taiwan 10
YT - Mayotte 10
AL - Albania 9
GF - Guiana Francese 9
KE - Kenya 9
LU - Lussemburgo 9
LY - Libia 9
MW - Malawi 9
PA - Panama 9
PR - Porto Rico 9
SN - Senegal 9
SO - Somalia 9
XK - ???statistics.table.value.countryCode.XK??? 9
YE - Yemen 9
AO - Angola 8
AU - Australia 8
DZ - Algeria 8
ET - Etiopia 8
HU - Ungheria 8
LT - Lituania 8
MD - Moldavia 8
TJ - Tagikistan 8
TT - Trinidad e Tobago 8
ZW - Zimbabwe 8
CM - Camerun 7
Totale 8.694
Città #
Ashburn 582
Fairfield 508
San Jose 508
Singapore 451
Woodbridge 319
Chandler 269
Ann Arbor 202
Houston 197
Hong Kong 195
Cambridge 172
Seattle 157
Ho Chi Minh City 150
Wilmington 141
Hanoi 120
Beijing 101
Santa Clara 83
Los Angeles 80
Boardman 62
New York 58
Council Bluffs 54
San Diego 48
Des Moines 44
Princeton 42
Da Nang 38
Lauterbourg 38
Munich 38
Medford 36
Bytom 35
Helsinki 35
Dublin 29
Chicago 27
Buffalo 23
Jacksonville 23
Nanjing 23
Tokyo 23
Frankfurt am Main 22
São Paulo 22
Haiphong 21
Abidjan 20
Milan 20
Baghdad 19
London 19
Orem 19
Roxbury 18
Dallas 17
Phoenix 16
Cotonou 15
Padova 15
Istanbul 14
Chennai 13
Kingston 13
Montreal 13
Rome 13
Toronto 13
Guayaquil 12
Warsaw 12
Amsterdam 11
Bishkek 11
Brooklyn 11
Johannesburg 11
Redondo Beach 11
Tashkent 11
Can Tho 10
Guangzhou 10
Jinan 10
Minsk 10
Montevideo 10
Shenyang 10
The Dalles 10
Yerevan 10
Amman 9
Atlanta 9
Bangkok 9
Brussels 9
Dakar 9
Hefei 9
Jeddah 9
Nassau 9
Nuremberg 9
Phnom Penh 9
Pristina 9
Quito 9
Riyadh 9
Stockholm 9
Vienna 9
Baku 8
Biên Hòa 8
Bắc Ninh 8
Cagliari 8
Denver 8
Dushanbe 8
Panama City 8
Paris 8
San José 8
Addis Ababa 7
Ankara 7
Bratislava 7
Bến Tre 7
Caracas 7
Conakry 7
Totale 5.652
Nome #
The left atrial appendage: from embryology to prevention of thromboembolism 363
Laboratory testing for antiphospholipid syndrome 290
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 285
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 282
Mitral valve anatomy and function: New insights from three-dimensional echocardiography 281
RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis 276
Antiphospholipid syndrome and the heart: A case series and literature review 275
Comprehensive analysis of left ventricular geometry and function by three-dimensional echocardiography in healthy adults 271
Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation 269
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles 264
Biologically safe colloidal suspensions of naked iron oxide nanoparticles for in situ antibiotic suppression 260
APS - Diagnostics and challenges for the future 256
Diagnosis and therapy of antiphospholipid syndrome 250
Laboratory Diagnostics of Antiphospholipid Syndrome 250
Colloidal maghemite nanoparticles with oxyhydroxide-like interface and chiroptical properties 250
European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation 238
Lupus anticoagulant testing: Diluted Russell Viper Venom Time (dRVVT) 232
H2O2 Tolerance in Pseudomonas Fluorescens: Synergy between Pyoverdine-Iron(III) Complex and a Blue Extracellular Product Revealed by a Nanotechnology-Based Electrochemical Approach 227
Do a vendor-specific and a vendor-independent software for 3D echocardiographic analysis provide similar values for left ventricular volumes and ejection fraction? 221
Current clinical applications of transthoracic three-dimensional echocardiography 221
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial 220
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study 219
A Bridging Protocol in High-Thrombotic Risk Mechanical Valve Bearers Undergoing Surgery or Invasive Procedures 215
Critical Role of Macrophages in Glucocorticoid Driven Vascular Calcification in a Mouse-Model of Atherosclerosis 213
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study 212
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation 211
Oral anticoagulation for atrial fibrillation in the era of non-vitamin K antagonist anticoagulants. Focus on very elderly patients 208
Quantitative analysis of mitral valve geometry by transthoracic three-dimensional echocardiography: reference values, feasibility and reproducibility 204
The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead? 202
The role of platelets in antiphospholipid syndrome 198
Fibroblast growth factor 23 and the bone-vascular axis: lessons learned from animal studies. 196
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma 189
Reasons and Consequences of Vitamin K Antagonists Discontinuation in Very Elderly Patients with Non-Valvular Atrial Fibrillation 187
Serial changes in high-sensitivity cardiac troponin, N-terminal pro-B-Type natriuretic peptide, and heart fatty acid binding protein during exercise echocardiography in patients with suspected angina pectoris and normal resting left ventricular function 185
Simultaneous Assessment of Myocardial Perfusion, Wall Motion, and Deformation during Myocardial Contrast Echocardiography: A Feasibility Study 183
Predictive value of 2D and 3D deformation parameters and wall motion score to identify transmural myocardial necrosis in STEMI patients: a comparative study against CMR 165
Reference values of right ventricular longitudinal strain by speckle tracking echocardiography in 219 healthy volunteers 164
Shift in relative contribution of radial and longitudinal mechanics to right ventricular ejection fraction between normal subjects and patients with pulmonary hypertension 162
Very Elderly Patients With Atrial Fibrillation Treated With Edoxaban 142
Endotoxin and phosphate may contribute to valve calcification by inducing an osteogenic profile in a specific subset of interstitial aortic valve cells 129
Totale 9.065
Categoria #
all - tutte 25.501
article - articoli 24.895
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.396


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022565 0 58 82 60 21 34 25 72 24 11 37 141
2022/2023512 91 62 14 66 63 72 2 45 57 4 30 6
2023/2024235 4 33 31 18 14 23 11 35 11 10 15 30
2024/20251.026 0 55 51 51 138 32 66 99 86 37 155 256
2025/20264.526 238 316 490 630 429 222 820 328 547 225 194 87
2026/2027262 140 122 0 0 0 0 0 0 0 0 0 0
Totale 9.065